Clinical Trials
Pumitamig + Chemotherapy vs. Bevacizumab + Chemotherapy in patients with previously untreated metastatic colon cancer
Disease Type: Colon
A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville